Average Co-Inventor Count = 6.46
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (10 from 3,923 patents)
2. Arrowhead Pharmaceuticals, Inc. (8 from 96 patents)
3. Arrowhead Research Corporation (2 from 18 patents)
20 patents:
1. 11208662 - RNAi inhibition of alpha-ENaC expression
2. 10550391 - Organic compositions to treat beta-ENaC-related diseases
3. 10544418 - RNAi inhibition of alpha-ENaC expression
4. 10081811 - Organic compositions to treat Beta-ENaC-related diseases
5. 9914927 - RNAi inhibition of alpha-ENaC expression
6. 9752152 - Organic compositions to treat beta-ENaC-related diseases
7. 9476052 - RNAi inhibition of alpha-ENaC expression
8. 9376683 - Organic compositions to treat beta-ENaC-related diseases
9. 9080175 - Organic compositions to treat Beta-ENaC-related diseases
10. 9074212 - RNAi inhibition of alpha-ENaC expression
11. 8598335 - Organic compositions to treat Beta-ENaC-related diseases
12. 8344129 - Organic compositions to treat Beta-ENaC-related diseases
13. 8344130 - Organic compositions to treat Beta-ENaC-related diseases
14. 8344131 - Organic compositions to treat beta-ENaC-related diseases
15. 8344127 - Organic compositions to treat beta-ENaC-related diseases